AIDS: Lessons from the Last Decade and Prospects for the Future

Centers for Disease Control: Pneumocystis pneumonia Los Angeles. MMWR 1981; 30: 250.

Centers for Disease Control: Update on acquired immunodeficiency syndrome (AIDS) United States. MMWR 1982; 31: 507.

Centers for Disease Control: HIV/AID Surveillance Survey, 1994; 6(1): 22.

Biggar R. , Rosenberg P. : HIV infection/AIDS in the U.S. during the 1990's. CLIN INFECT DIS 1993; 17: S219.

Kingsley L.A. , Zahou S.Y. , Bacellar H. : Temporal trends in human immunodeficiency virus Type I seroconversion 1984–1989: a report from the multicenter AIDS cohort study (MACS). AM J EPIDEMIOL 1991; 34: 331.

Centers for Disease Control: Update: acquired immunodeficiency syndrome United States, 1992. MMWR 1993; 42: 547.

Centers for Disease Control: Heterosexually acquired AIDS United States, 1993. MMWR 1994; 43: 155.

Mann J. , Welles S. : Global aspects of the HIV epidemic in AIDS: etiology, diagnosis, treatment and prevention. Third Edition 1992: 89.

Centers for Disease Control: Update: acquired immunodeficiency syndrome associated with intravenous drug use United States, 1988. MMWR 1989; 38: 165.

Naik T.M. , Sarkar S. , Singh H.L. : Intravenous drug users. Anew high-risk group of HIV infection in India. AIDS 1991; 5: 117.

Donegan E. , Lewis B. , Tomasulo P. , Mosley J. : Transfusion safety study group: transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion 1990; 30: 851.

Cummings P.D. , Wallace E.L. , Schan J.B. , Dodd R.Y. : Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative. N Engl J Med 1989; 321: 940.

Donahue J.G. , Nelson K.E. , Munoz A. : Transmission of HIV by transfusion of screened blood. N Engl J Med 1990; 323: 1709.

Volkow P. Paid plasma donors: a risk group for HIV transmission not fully recognized. J ACQUIR IMMUNE DEFIC SYNDR 1992; 5: 949.

Hersh B.S. , Popovici F. , Apeterei R. : Acquired immunodeficiency syndrome in Romania. Lancet 1991; 338: 645.

Smith M.S. , Brian E.L. , Pagano J.S. : Resumption of virus production after HIV infection of T-lymphocytes in the presence of azidothymidine. J Virol 1987; 61: 3769.

Fischel M.A. , Richman D.D. , Grieco M.H. : The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related comples: a double blind, placebo controlled trial. N Engl J Med 1987; 317: 185.

Fischel M.A. , Richman D.D. , Hansen N. : The safety and efficacy of zidovudine in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I infection: a double blind placebo controlled trial. Ann Intern Med 1990; 112: 727.

Connor E.M. , Sperling R.S. , Gelber R. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331(18): 1173–80.

Volberding P.A. , Logakos S.W. , Koch M.A. : Zidovudine in asymptomatic human immunodeficiency virus infections. A controlled trial in persons with fewer than 500 CD4 positive cells per cubic millimeter. N Engl J Med 1990; 322: 941.

O'Brien R.F. , Quinn J.L. , Muakara B.T. Diagnosis of Pneumocystis carinii pneumonia by induced sputum in a city with moderate incidence of AIDS. Chest 1989; 95: 136.

Golden J.A. , Hollander H. , Stulborg M.S. , Gomsu G. : Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pnemonia, Chest 1986; 90: 18.

The National Institutes of Health - University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis carinii pneumonia: consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1500.

Jones B.E. , Young S.M.M. , Antonisku D. : Relationship of the manifestations of tuberculosis to CD4 counts in patients with human immunodeficiency virus infection. Am Rev Resp Dis 1993; 148: 1292.

Penn I. : Lymphomas complicating organ transplantation. Transplant Proc 1983; 15(suppl 1): 2790.

Metzer D.S. , Woody G.E. , Mclellan A.T. Human immunodeficiency virus seroconversion amoung intravenous drug users in-and out-of-treatment: an 18 mo. prospective follow-up. J Acquir Immune Defic Syndr 1993; 6: 1049.

Ljungberg B. , Andersson B. , Christensson B. : HIV prevention among injecting drug users: Three years of experience with a syringe exchange program in Sweden. J AIDS 1991; 4: 890.

Weibel W. , Jimenez A. , Johnson W. Positive effect on HIV seroconversion of street outreach intervention with IDU in Chicago: 1988–1992. IX International Conference on AIDS/IV STD World Congress. Berlin, June 1993 (abstract WSC152) 29. Nowak MA Science 1991; 254: 963.